Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorHUQ, A. J.
dc.contributor.authorWALSH, M.
dc.contributor.authorRAJAGOPALAN, B.
dc.contributor.authorFINLAY, M.
dc.contributor.authorTRAINER, A. H.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBONNET, Fabrice
dc.contributor.authorSEVENET, N.
dc.contributor.authorWINSHIP, I. M.
dc.date.accessioned2020-11-17T09:24:54Z
dc.date.available2020-11-17T09:24:54Z
dc.date.issued2018-10
dc.identifier.issn1389-9600en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/14054
dc.description.abstractEnMany cancer predisposition syndromes are preceded or accompanied by a range of typical skin signs. Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the PTCH1 gene. Approximately 5% of cases have been attributed to a mutation in the SUFU gene. Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas. Recently hamartomatous skin lesions have also been noted in families with childhood medulloblastoma, a "Gorlin like" phenotype and a SUFU mutation. Here we describe a family previously diagnosed with Gorlin syndrome with a novel SUFU splice site deleterious genetic variant, who have several dermatological features including palmar sclerotic fibromas which has not been described in relation to a SUFU mutation before. We highlight the features more prominent in individuals with a SUFU mutation. It is important to note that emerging therapies for treatment of BCCs in patients with a PTCH1 mutation may not be effective in those with a SUFU mutation.
dc.language.isoENen_US
dc.subject.enMORPH3Eus
dc.title.enMutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same
dc.title.alternativeFam Canceren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1007/s10689-018-0073-7en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29356994en_US
bordeaux.journalFamilial canceren_US
bordeaux.page601-606en_US
bordeaux.volume17en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamMORPH3Eusen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03009177
hal.version1
hal.date.transferred2020-11-17T09:25:00Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Familial%20cancer&rft.date=2018-10&rft.volume=17&rft.issue=4&rft.spage=601-606&rft.epage=601-606&rft.eissn=1389-9600&rft.issn=1389-9600&rft.au=HUQ,%20A.%20J.&WALSH,%20M.&RAJAGOPALAN,%20B.&FINLAY,%20M.&TRAINER,%20A.%20H.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée